Implications of androgen receptor (AR) alterations identified by genomic testing of tissue and blood from advanced prostate cancer (aPC) patients (pts).

Authors

Zeynep Zengin

Zeynep Busra Zengin

City of Hope Comprehensive Cancer Center, Duarte, CA

Zeynep Busra Zengin , Nicholas Henderson , Joseph J. Park , Alicia Ali , Clara Hwang , Pedro C. Barata , Mehmet Asim Bilen , Laura Graham , Deepak Kilari , Abhishek Tripathi , Matthew Labriola , Shoshana Rothstein , Rohan Garje , Vadim S Koshkin , Vaibhav G. Patel , Michael Thomas Schweizer , Andrew J. Armstrong , Rana R. McKay , Ajjai Shivaram Alva , Tanya B. Dorff

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Translational Research, Tumor Biology, Biomarkers, and Pathology

Citation

J Clin Oncol 40, 2022 (suppl 6; abstr 138)

DOI

10.1200/JCO.2022.40.6_suppl.138

Abstract #

138

Poster Bd #

G12

Abstract Disclosures

Similar Posters

First Author: Alicia K. Morgans

First Author: Arpit Rao